Janssen

Radboudumc and Janssen

Radboudumc and Radboud University have been working closely with Janssen (Janssen Pharmaceutica NV, Janssen-Cilag B.V. and Janssen Vaccines & Prevention B.V.) since 2019. The collaboration focuses on, among other things:

• scientific research and stimulation of talent, including in oncology and immunology
• molecules/products/platforms
• technology and licensing opportunities
• digital health
• clinical activities
• sustainability, SDGs, and sustainable availability of medicines
• broader innovation ecology of health care system

Radboudumc has a strong focus on sustainable, innovative and affordable patient care. Janssen, part of Johnson & Johnson, is a global player in the pharmaceutical industry. The collaboration creates a unique synergy between research, education, care, and valorization. Through this creative interaction, promising projects surface and lead to concrete results more quickly.

The collaboration enables researchers to link high quality academic innovative research even better to the translation capabilities of the industry. Biomedical, pharmaceutical, and clinical research will thus become available to the patient more quickly.